CSIMarket Company Name, Ticker, Suppliers, else..
 
Organigram Global Inc   (NASDAQ: OGI)
 
Price: $1.1200 $-0.03 -3.030%
Day's High: $1.149999976158142 Week Perf: -5.08 %
Day's Low: $ 1.10 30 Day Perf: 13.13 %
Volume (M): 1,211,003 52 Wk High: $ 2.24
Volume (M$): $ 0 52 Wk Avg: $1.42
Open: $1.15 52 Wk Low: $0.85



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 800
 Revenues (TTM) (Millions $) 199
 Net Income (TTM) (Millions $) -19
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 13

Business Description


Organigram Holdings Inc is a Canadian company specializing in the production and distribution of cannabis products. Founded in 2013, the company operates out of a state-of-the-art facility in Moncton, New Brunswick. Organigram is committed to producing high-quality, organic cannabis products through sustainable cultivation practices. The company offers a wide range of products including dried flower, oils, and edibles, catering to both the medical and recreational cannabis markets. With a focus on innovation and customer satisfaction, Organigram has established itself as a leading player in the rapidly growing cannabis industry.


   Company Address: 1400-145 King Street West Toronto 0 ON
   Company Phone Number: 644-4726   Stock Exchange / Ticker: NASDAQ OGI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CPMD      0% 
CVSI   -13.5%    
ETST        1.06% 
IGC   -3.37%    
INM   -1.48%    
LIFD      0% 
• View Complete Report
   



Business Update

s with its groundbreaking advancements in cannabis technology. The company recently completed a landmark clinical pha...

Published Tue, Mar 25 2025 3:54 AM UTC

Organigram Transitions to Organigram Global Inc. Amidst Strategic Developments and Groundbreaking Innovations in Cannabis Technology TORONTO March 24, 2025 In a significant move towards enhancing its global presence, Organigram Holdings Inc. (TSX: OGI, NASDAQ: OGI) has announced the results of its annual general and special meeting of shareholders, confirming the appro...
Business Update

Organigrams Innovative Gummies Shaping the Future of Cannabis Consumption

Published Tue, Nov 26 2024 11:47 AM UTC

TORONTO In a compelling leap forward for cannabis innovation, Organigram Holdings Inc. has announced the launch of its Edison Sonics gummies, marking a pivotal moment for the industry with the introduction of its groundbreaking FAST nanoemulsion technology. This pioneering product is not just another addition to the edibles market; it promises an unprecedented experience ...
Business Update

Organigram Secures Robust Strategic Investment from British American Tobacco, Fortifying Its Market Leadership in the...

Published Tue, Sep 3 2024 11:47 AM UTC

Organigram Secures Second Tranche in Strategic Equity Investment from British American Tobacco Organigram Holdings Inc. (NASDAQ: OGI, TSX: OGI) has demonstrated its ongoing commitment to becoming a leader in the cannabis industry by closing the second tranche of a substantial equity investment from BT DE Investments Inc. a wholly owned subsidiary of British American Tobacco ...
Business Update

Organigrams Nanoemulsion Technology Marks a Breakthrough in Cannabis Product Development

Published Wed, Aug 7 2024 11:51 AM UTC

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis, is thrilled to announce the preliminary results of its pioneering clinical pharmacokinetic (PK) study, marking a significant milestone in cannabis delivery innovation. The study was conducted through Organigram’s Product Development Collaboration (PDC) and focused on its cutting-edg...
Business Update

Organigram Plants Seeds for Growth with $1M Investment in Phylos to Expand Auto-Flower and Rare Cannabinoi...

Published Wed, Jul 24 2024 10:21 AM UTC

Toronto, Canada Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), referred to henceforth as Organigram, has taken a significant step in enhancing its cannabis genetics and seed portfolio. The company, a prominent licensed producer of cannabis, announced today that it has completed an early partial funding of its final third tranche investment into Phylos Bioscience Inc. (...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.22
Working Capital Ratio 2.26
Leverage Ratio (MRQ) 0.61
Total Debt to Equity 0.04
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 248,168
Net Income per Employee (TTM) -23,707
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.46

Profitability Ratios Current
Gross Margin (MRQ) 34.81 %
Operating Margin (MRQ) -5.9 %
Net Margin (MRQ) -9.55 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Organigram Global Inc's Segments
Recreational revenue Canadian    140.75 % of total Revenue
Direct to patient medical and medical wholesale revenue Canadian    0.93 % of total Revenue
International wholesale    10.16 % of total Revenue
Wholesale to licensed producers Canadian    3.61 % of total Revenue
Other revenue    0.05 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.